Clinical Trial Update: IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial SINAPPS2 evaluates intravenous immunoglobulin (IVIG) and rituximab for antibody-associated psychosis linked to autoimmune encephalitis; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis
• Psychosis

Drugs mentioned

• IVIG (intravenous immunoglobulin)
• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: University of Cambridge | Conditions: Psychosis, Autoimmune Encephalitis | Phase 2 | Status: RECRUITING